Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
Lin, Chia-Chi, Calvo, Emiliano, Papadopoulos, Kyriakos P, Patnaik, Amita, Sarantopoulos, John, Mita, Alain C, Preston, Glenn G, Mita, Monica M, Rodon, Jordi, Mays, Theresa, Yeh, I-Tien, O'Rourke, Pat, Takimoto, Chris H, Dancey, Janet E, Chen, Helen, Tolcher, Anthony W
Published in Cancer chemotherapy and pharmacology (01.05.2009)
Published in Cancer chemotherapy and pharmacology (01.05.2009)
Get full text
Journal Article
Phase I pharmacokinetic study of dasatinib (BMS-354825) in patients with advanced malignancies and varying levels of liver dysfunction: S0711, a SWOG early therapeutics committee study
Sarantopoulos, John, Hoering, Antje, Synold, Timothy W., Mahalingam, Devalingam, Wang, Ding, Lenz, Heinz-Josef, O'Rourke, Pat, Sexton, Rachel, Van Veldhuizen, Peter J., Mita, Monica M., Wong, Lucas, Mita, Alain C., El-Khoueiry, Anthony B., Chung, Vincent M., Gandara, David R., Tejwani, Sheela, Takebe, Naoko, Takimoto, Chris H.M., Ivy, S. Percy, Kurzrock, Razelle
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article